Showing results (561-570 of 887) with videos related to
Sort By:
Pageof 89
Clinical Kidney Journal|August 8, 2015
High convection volume in online post-dilution haemodiafiltration: relevance, safety and costsIra M Mostovaya, Muriel P C Grooteman, Carlo Basile, et al.Clinical Research in Cardiology : Official Journal of the German Cardiac Society|May 26, 2018
Value of the CHA2DS2-VASc score and Fabry-specific score for predicting new-onset or recurrent stroke/TIA in Fabry disease patients without atrial fibrillationDan Liu, Kai Hu, Marie Schmidt, et al.The New England Journal of Medicine|June 15, 2016
Empagliflozin and Progression of Kidney Disease in Type 2 DiabetesChristoph Wanner, Silvio E Inzucchi, John M Lachin, et al.Atherosclerosis. Supplements|November 4, 2017
CaRe high - Cascade screening and registry for high cholesterol in GermanyNina Schmidt, Tanja Grammer, Ioanna Gouni-Berthold, et al.ESC Heart Failure|June 16, 2021
Time to cardiovascular benefits of empagliflozin: a post hoc observation from the EMPA-REG OUTCOME trialSubodh Verma, Lawrence A Leiter, Bernard Zinman, et al.The American Journal of Medicine|July 9, 2010
Department-related tasks and organ-targeted therapy in Fabry disease: an interdisciplinary challengeFrank Weidemann, Claudia Sommer, Thomas Duning, et al.Clinical Journal of the American Society of Nephrology : CJASN|January 22, 2013
Low plasma α-tocopherol concentrations and adverse clinical outcomes in diabetic hemodialysis patientsKatharina M Espe, Jens Raila, Andrea Henze, et al.Diabetes, Obesity & Metabolism|May 5, 2021
Effect of empagliflozin on cardiorenal outcomes and mortality according to body mass index: A subgroup analysis of the EMPA-REG OUTCOME trial with a focus on AsiaQiuhe Ji, Linong Ji, Yiming Mu, et al.Journal of the American Society of Nephrology : JASN|January 5, 2000
Lipoprotein(a) serum concentrations and apolipoprotein(a) phenotypes in mild and moderate renal failureFlorian Kronenberg, Erich Kuen, Eberhard Ritz, et al.Experimental Gerontology|January 22, 2013
Circulating aldosterone and mortality in female nursing home residentsAndreas Tomaschitz, Stefan Pilz, Burkert Pieske, et al.Pageof 89